Login
About Alexion
Our Leadership
Our Partnerships
Our Ethical Standards
Our History
Patient Focus
Advocacy
Patient Stories
Products
Soliris
®
PNH
aHUS
Strensiq
®
Kanuma
®
Research & Development
Our Pipeline
Development Programs
Investigator-Sponsored Research
Discovery Partnerships
Responsibility
Global Access to Medicines Policy
Main Menu
Careers
Job Opportunities
Why Choose Alexion
Culture
Compensation & Benefits
Work/Life Balance
Health & Wellness
Financial Security
Recognition & Rewards
Personal Growth & Development
Professional Development
Select a Country
North America
Canada
USA
Latin America
Argentina
Brazil
Colombia
Mexico
Europe, the Middle East & Africa
Alexion Europe
Belgium
Denmark
France
Germany
Ireland
Italy
Netherlands
Norway
Russia
Spain
Sweden
Switzerland
Turkey
UAE
UK
Asia Pacific
Australia
China
India
Japan
Investors
News
Contact
Select a Country
Investors
News
Contact
Search for:
North America
Canada
United States
Latin America
Argentina
Brazil
Colombia
Mexico
Europe, the Middle East & Africa
Alexion Europe
Belgium
Denmark
France
Germany
Ireland
Italy
Netherlands
Norway
Russia
Spain
Sweden
Switzerland
Turkey
UAE
United Kingdom
Asia Pacific
Australia
China
India
Japan
About Alexion
Patient Focus
Products
Research & Development
Responsibility
Careers
Select a Country
North America
Canada
USA
Latin America
Argentina
Brazil
Colombia
Mexico
Europe, the Middle East & Africa
Alexion Europe
Belgium
Denmark
France
Germany
Ireland
Italy
Netherlands
Norway
Russia
Spain
Sweden
Switzerland
Turkey
UAE
UK
Asia Pacific
Australia
China
India
Japan
Investors
News
Contact
Home
»
Newsroom
»
Press Releases
Press Releases
Press Releases
Filter by Category
All Press Releases
Company Releases
Company Statements
Financial Releases
Product Releases
Sort by Year
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
Media
Inquiries
Media
Materials
Email
Alerts
All News Releases
Search:
Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast
January 28, 2008
HTML
PDF
Alexion to Present at the Wachovia Securities 2008 Healthcare Conference
January 24, 2008
HTML
PDF
Alexion Commences Dosing in AEGIS Registration Study of Soliris® (eculizumab) in Patients with PNH in Japan
January 7, 2008
HTML
PDF
Alexion to Present at the 26th Annual JP Morgan Healthcare Conference
January 2, 2008
HTML
PDF
PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris® Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
December 11, 2007
HTML
PDF
Long-Term Soliris® Therapy Improved or Stabilized Kidney Function in Patients With PNH
December 10, 2007
HTML
PDF
Alexion Pharmaceuticals to Present Data on Soliris® (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting
December 7, 2007
HTML
PDF
Soliris® Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
December 4, 2007
HTML
PDF
Alexion Pharmaceuticals to Present Data on Soliris® (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting
November 9, 2007
HTML
PDF
Alexion to Present at Investor Conferences
November 6, 2007
HTML
PDF
« first
‹ previous
…
41
42
43
44
45
46
47
48
49
next ›
last »
